The global polymerase chain reaction market size accounted for USD 9.55 billion in 2024, grew to USD 10.46 billion in 2025 and is predicted to surpass around USD 23.66 billion by 2034, representing a healthy CAGR of 9.50% between 2024 and 2034. The North America polymerase chain reaction market size is calculated at USD 3.82 billion in 2024 and is expected to grow at a fastest CAGR of 9.61% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Polymerase Chain Reaction Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Polymerase Chain Reaction Market, by Type, 2024-2034
8.1.1. Conventional PCR
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Others
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. Polymerase Chain Reaction Market, by Product, 2024-2034
9.1.1. Consumables & Reagents
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Software & Services
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Instruments
9.1.3.1. Market Revenue and Forecast (2021-2034)
10.1. Polymerase Chain Reaction Market, by Application, 2024-2034
10.1.1. Medical
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Non-medical
10.1.2.1. Market Revenue and Forecast (2021-2034)
11.1. Polymerase Chain Reaction Market, by Indication, 2024-2034
11.1.1. Infectious Diseases
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Oncology
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Genetic Disorders
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2021-2034)
12.1. Polymerase Chain Reaction Market, by End User, 2024-2034
12.1.1. Hospitals & Clinics
12.1.1.1. Market Revenue and Forecast (2021-2034)
12.1.2. Pharmaceutical & Biotechnology Industries
12.1.2.1. Market Revenue and Forecast (2021-2034)
12.1.3. Diagnostic Centers
12.1.3.1. Market Revenue and Forecast (2021-2034)
12.1.4. Academic & Research Organization
12.1.4.1. Market Revenue and Forecast (2021-2034)
13.1. North America
13.1.1. Market Revenue and Forecast, by Type (2021-2034)
13.1.2. Market Revenue and Forecast, by Product (2021-2034)
13.1.3. Market Revenue and Forecast, by Application (2021-2034)
13.1.4. Market Revenue and Forecast, by Indication (2021-2034)
13.1.5. Market Revenue and Forecast, by End User (2021-2034)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Type (2021-2034)
13.1.6.2. Market Revenue and Forecast, by Product (2021-2034)
13.1.6.3. Market Revenue and Forecast, by Application (2021-2034)
13.1.6.4. Market Revenue and Forecast, by Indication (2021-2034)
13.1.6.5. Market Revenue and Forecast, by End User (2021-2034)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Type (2021-2034)
13.1.7.2. Market Revenue and Forecast, by Product (2021-2034)
13.1.7.3. Market Revenue and Forecast, by Application (2021-2034)
13.1.7.4. Market Revenue and Forecast, by Indication (2021-2034)
13.1.7.5. Market Revenue and Forecast, by End User (2021-2034)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Type (2021-2034)
13.2.2. Market Revenue and Forecast, by Product (2021-2034)
13.2.3. Market Revenue and Forecast, by Application (2021-2034)
13.2.4. Market Revenue and Forecast, by Indication (2021-2034)
13.2.5. Market Revenue and Forecast, by End User (2021-2034)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Type (2021-2034)
13.2.6.2. Market Revenue and Forecast, by Product (2021-2034)
13.2.6.3. Market Revenue and Forecast, by Application (2021-2034)
13.2.7. Market Revenue and Forecast, by Indication (2021-2034)
13.2.8. Market Revenue and Forecast, by End User (2021-2034)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Type (2021-2034)
13.2.9.2. Market Revenue and Forecast, by Product (2021-2034)
13.2.9.3. Market Revenue and Forecast, by Application (2021-2034)
13.2.10. Market Revenue and Forecast, by Indication (2021-2034)
13.2.11. Market Revenue and Forecast, by End User (2021-2034)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Type (2021-2034)
13.2.12.2. Market Revenue and Forecast, by Product (2021-2034)
13.2.12.3. Market Revenue and Forecast, by Application (2021-2034)
13.2.12.4. Market Revenue and Forecast, by Indication (2021-2034)
13.2.13. Market Revenue and Forecast, by End User (2021-2034)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Type (2021-2034)
13.2.14.2. Market Revenue and Forecast, by Product (2021-2034)
13.2.14.3. Market Revenue and Forecast, by Application (2021-2034)
13.2.14.4. Market Revenue and Forecast, by Indication (2021-2034)
13.2.15. Market Revenue and Forecast, by End User (2021-2034)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Type (2021-2034)
13.3.2. Market Revenue and Forecast, by Product (2021-2034)
13.3.3. Market Revenue and Forecast, by Application (2021-2034)
13.3.4. Market Revenue and Forecast, by Indication (2021-2034)
13.3.5. Market Revenue and Forecast, by End User (2021-2034)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Type (2021-2034)
13.3.6.2. Market Revenue and Forecast, by Product (2021-2034)
13.3.6.3. Market Revenue and Forecast, by Application (2021-2034)
13.3.6.4. Market Revenue and Forecast, by Indication (2021-2034)
13.3.7. Market Revenue and Forecast, by End User (2021-2034)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Type (2021-2034)
13.3.8.2. Market Revenue and Forecast, by Product (2021-2034)
13.3.8.3. Market Revenue and Forecast, by Application (2021-2034)
13.3.8.4. Market Revenue and Forecast, by Indication (2021-2034)
13.3.9. Market Revenue and Forecast, by End User (2021-2034)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Type (2021-2034)
13.3.10.2. Market Revenue and Forecast, by Product (2021-2034)
13.3.10.3. Market Revenue and Forecast, by Application (2021-2034)
13.3.10.4. Market Revenue and Forecast, by Indication (2021-2034)
13.3.10.5. Market Revenue and Forecast, by End User (2021-2034)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Type (2021-2034)
13.3.11.2. Market Revenue and Forecast, by Product (2021-2034)
13.3.11.3. Market Revenue and Forecast, by Application (2021-2034)
13.3.11.4. Market Revenue and Forecast, by Indication (2021-2034)
13.3.11.5. Market Revenue and Forecast, by End User (2021-2034)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Type (2021-2034)
13.4.2. Market Revenue and Forecast, by Product (2021-2034)
13.4.3. Market Revenue and Forecast, by Application (2021-2034)
13.4.4. Market Revenue and Forecast, by Indication (2021-2034)
13.4.5. Market Revenue and Forecast, by End User (2021-2034)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Type (2021-2034)
13.4.6.2. Market Revenue and Forecast, by Product (2021-2034)
13.4.6.3. Market Revenue and Forecast, by Application (2021-2034)
13.4.6.4. Market Revenue and Forecast, by Indication (2021-2034)
13.4.7. Market Revenue and Forecast, by End User (2021-2034)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Type (2021-2034)
13.4.8.2. Market Revenue and Forecast, by Product (2021-2034)
13.4.8.3. Market Revenue and Forecast, by Application (2021-2034)
13.4.8.4. Market Revenue and Forecast, by Indication (2021-2034)
13.4.9. Market Revenue and Forecast, by End User (2021-2034)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Type (2021-2034)
13.4.10.2. Market Revenue and Forecast, by Product (2021-2034)
13.4.10.3. Market Revenue and Forecast, by Application (2021-2034)
13.4.10.4. Market Revenue and Forecast, by Indication (2021-2034)
13.4.10.5. Market Revenue and Forecast, by End User (2021-2034)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Type (2021-2034)
13.4.11.2. Market Revenue and Forecast, by Product (2021-2034)
13.4.11.3. Market Revenue and Forecast, by Application (2021-2034)
13.4.11.4. Market Revenue and Forecast, by Indication (2021-2034)
13.4.11.5. Market Revenue and Forecast, by End User (2021-2034)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Type (2021-2034)
13.5.2. Market Revenue and Forecast, by Product (2021-2034)
13.5.3. Market Revenue and Forecast, by Application (2021-2034)
13.5.4. Market Revenue and Forecast, by Indication (2021-2034)
13.5.5. Market Revenue and Forecast, by End User (2021-2034)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Type (2021-2034)
13.5.6.2. Market Revenue and Forecast, by Product (2021-2034)
13.5.6.3. Market Revenue and Forecast, by Application (2021-2034)
13.5.6.4. Market Revenue and Forecast, by Indication (2021-2034)
13.5.7. Market Revenue and Forecast, by End User (2021-2034)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Type (2021-2034)
13.5.8.2. Market Revenue and Forecast, by Product (2021-2034)
13.5.8.3. Market Revenue and Forecast, by Application (2021-2034)
13.5.8.4. Market Revenue and Forecast, by Indication (2021-2034)
13.5.8.5. Market Revenue and Forecast, by End User (2021-2034)
14.1. Abbott
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Agilent Technologies, Inc.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Fluidigm Corporation
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Cytiva
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Stilla Technologies
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Microsynth AG
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. JN Medsys
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Danaher Corporation
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Qiagen
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Thermo Fisher Scientific, Inc.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample